Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Phibro Animal Health ( (PAHC) ).
On February 3, 2026, Phibro Animal Health Corporation’s board declared a quarterly cash dividend of $0.12 per share on both its Class A and Class B common stock, payable on March 25, 2026 to shareholders of record as of March 4, 2026, underscoring the company’s continued commitment to returning capital to investors and signaling confidence in its ongoing financial position within the animal health and nutrition sector.
The most recent analyst rating on (PAHC) stock is a Sell with a $32.00 price target. To see the full list of analyst forecasts on Phibro Animal Health stock, see the PAHC Stock Forecast page.
Spark’s Take on PAHC Stock
According to Spark, TipRanks’ AI Analyst, PAHC is a Neutral.
Phibro Animal Health’s strong earnings call performance and increased guidance are the most significant factors driving the score. However, financial risks from high leverage and negative cash flow growth, along with bearish technical indicators, moderate the overall score.
To see Spark’s full report on PAHC stock, click here.
More about Phibro Animal Health
Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company that partners with livestock producers, farmers, veterinarians and consumers, providing solutions to help maintain and enhance the health of farm and companion animals.
Average Trading Volume: 268,845
Technical Sentiment Signal: Buy
Current Market Cap: $1.63B
Learn more about PAHC stock on TipRanks’ Stock Analysis page.